Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Polymorphisms in FFAR4 (GPR120) Gene Modulate Insulin Levels and Sensitivity after Fish Oil Supplementation.

Vallée Marcotte B, Cormier H, Rudkowska I, Lemieux S, Couture P, Vohl MC.

J Pers Med. 2017 Nov 6;7(4). pii: E15. doi: 10.3390/jpm7040015.

2.

Epigenetic changes in blood leukocytes following an omega-3 fatty acid supplementation.

Tremblay BL, Guénard F, Rudkowska I, Lemieux S, Couture P, Vohl MC.

Clin Epigenetics. 2017 Apr 26;9:43. doi: 10.1186/s13148-017-0345-3. eCollection 2017.

3.

Effects of a nutraceutical combination on lipids, inflammation and endothelial integrity in patients with subclinical inflammation: a randomized clinical trial.

Pirro M, Mannarino MR, Ministrini S, Fallarino F, Lupattelli G, Bianconi V, Bagaglia F, Mannarino E.

Sci Rep. 2016 Mar 23;6:23587. doi: 10.1038/srep23587.

4.

Expression and Sequence Variants of Inflammatory Genes; Effects on Plasma Inflammation Biomarkers Following a 6-Week Supplementation with Fish Oil.

Cormier H, Rudkowska I, Lemieux S, Couture P, Vohl MC.

Int J Mol Sci. 2016 Mar 15;17(3):375. doi: 10.3390/ijms17030375.

5.

Association between polymorphisms in phospholipase A2 genes and the plasma triglyceride response to an n-3 PUFA supplementation: a clinical trial.

Tremblay BL, Cormier H, Rudkowska I, Lemieux S, Couture P, Vohl MC.

Lipids Health Dis. 2015 Feb 21;14:12. doi: 10.1186/s12944-015-0009-2.

6.

Impact of milk consumption on cardiometabolic risk in postmenopausal women with abdominal obesity.

Drouin-Chartier JP, Gagnon J, Labonté MÈ, Desroches S, Charest A, Grenier G, Dodin S, Lemieux S, Couture P, Lamarche B.

Nutr J. 2015 Jan 21;14:12. doi: 10.1186/1475-2891-14-12.

7.

Genome-wide association study of the plasma triglyceride response to an n-3 polyunsaturated fatty acid supplementation.

Rudkowska I, Guénard F, Julien P, Couture P, Lemieux S, Barbier O, Calder PC, Minihane AM, Vohl MC.

J Lipid Res. 2014 Jul;55(7):1245-53. doi: 10.1194/jlr.M045898. Epub 2014 May 19.

8.

Vulnerable blood in high risk vascular patients: study design and methods.

McDermott MM, Greenland P, Liu K, Tian L, Green D, Shah SJ, Huffman M, Wilkins J, Kibbe M, Liao Y, Huang CC, Skelly C, Jacobs C, McCarthy W, Auerbach A, Lloyd-Jones D.

Contemp Clin Trials. 2014 May;38(1):121-9. doi: 10.1016/j.cct.2014.03.009. Epub 2014 Apr 8.

9.

Polymorphisms in Fatty Acid Desaturase (FADS) Gene Cluster: Effects on Glycemic Controls Following an Omega-3 Polyunsaturated Fatty Acids (PUFA) Supplementation.

Cormier H, Rudkowska I, Thifault E, Lemieux S, Couture P, Vohl MC.

Genes (Basel). 2013 Sep 10;4(3):485-98. doi: 10.3390/genes4030485.

10.

Associations between dietary patterns and gene expression profiles of healthy men and women: a cross-sectional study.

Bouchard-Mercier A, Paradis AM, Rudkowska I, Lemieux S, Couture P, Vohl MC.

Nutr J. 2013 Feb 12;12:24. doi: 10.1186/1475-2891-12-24.

11.

Differences in metabolomic and transcriptomic profiles between responders and non-responders to an n-3 polyunsaturated fatty acids (PUFAs) supplementation.

Rudkowska I, Paradis AM, Thifault E, Julien P, Barbier O, Couture P, Lemieux S, Vohl MC.

Genes Nutr. 2013 Jul;8(4):411-23. doi: 10.1007/s12263-012-0328-0. Epub 2012 Dec 19.

12.

Population-based study of high plasma C-reactive protein concentrations among the Inuit of Nunavik.

Labonté ME, Dewailly E, Chateau-Degat ML, Couture P, Lamarche B.

Int J Circumpolar Health. 2012;71. doi: 10.3402/ijch.v71i0.19066. Epub 2012 Oct 17.

13.

Association between polymorphisms in the fatty acid desaturase gene cluster and the plasma triacylglycerol response to an n-3 PUFA supplementation.

Cormier H, Rudkowska I, Paradis AM, Thifault E, Garneau V, Lemieux S, Couture P, Vohl MC.

Nutrients. 2012 Aug;4(8):1026-41. Epub 2012 Aug 17.

14.

Molecular biology of atherosclerosis.

Mannarino E, Pirro M.

Clin Cases Miner Bone Metab. 2008 Jan;5(1):57-62.

15.

Atorvastatin increases intestinal expression of NPC1L1 in hyperlipidemic men.

Tremblay AJ, Lamarche B, Lemelin V, Hoos L, Benjannet S, Seidah NG, Davis HR Jr, Couture P.

J Lipid Res. 2011 Mar;52(3):558-65. doi: 10.1194/jlr.M011080. Epub 2010 Dec 1.

16.

Biomarkers in peripheral arterial disease patients and near- and longer-term mortality.

Criqui MH, Ho LA, Denenberg JO, Ridker PM, Wassel CL, McDermott MM.

J Vasc Surg. 2010 Jul;52(1):85-90. doi: 10.1016/j.jvs.2010.02.004. Epub 2010 May 14.

17.

The Levels of Inflammatory Markers in the Treatment of Stroke study (LIMITS): inflammatory biomarkers as risk predictors after lacunar stroke.

Elkind MS, Luna JM, Coffey CS, McClure LA, Liu KM, Spitalnik S, Paik MC, Roldan A, White C, Hart R, Benavente O.

Int J Stroke. 2010 Apr;5(2):117-25. doi: 10.1111/j.1747-4949.2010.00420.x.

18.

The use of high-sensitivity assays for C-reactive protein in clinical practice.

Musunuru K, Kral BG, Blumenthal RS, Fuster V, Campbell CY, Gluckman TJ, Lange RA, Topol EJ, Willerson JT, Desai MY, Davidson MH, Mora S.

Nat Clin Pract Cardiovasc Med. 2008 Oct;5(10):621-35. doi: 10.1038/ncpcardio1322. Epub 2008 Aug 19. Review.

19.

Insulin resistance syndrome, body mass index and the risk of ischemic heart disease.

St-Pierre AC, Cantin B, Mauriège P, Bergeron J, Dagenais GR, Després JP, Lamarche B.

CMAJ. 2005 May 10;172(10):1301-5.

20.

Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity.

Vaudo G, Marchesi S, Gerli R, Allegrucci R, Giordano A, Siepi D, Pirro M, Shoenfeld Y, Schillaci G, Mannarino E.

Ann Rheum Dis. 2004 Jan;63(1):31-5.

Supplemental Content

Support Center